TSPAN33

Across TCGA pan-cancer cohorts, TSPAN33 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TSPAN33 data layer compared with 23 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher TSPAN33 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TSPAN33 expression acts as an unfavorable survival marker.

COAD and BLCA are the cancer types where TSPAN33 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.056	0.871	<.001	36	view →
BLCA	OS	Median	III,IV	0.153	0.684	.001	21	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

TSPAN33–COAD (OS)

Open the COAD breakdown →